Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
The company has also been named among global sustainability leaders for the 7th year in a row in the Dow Jones Sustainability Index in the Emerging Markets category
_256_384.jpg)
The company is proud to be at the forefront of promoting cancer awareness and hopes to make a positive impact on the lives of its employees
Subscribe To Our Newsletter & Stay Updated
